WuXi Biologics (Cayman) Inc. (HKG:2269)
33.94
+0.24 (0.71%)
Apr 29, 2026, 4:08 PM HKT
WuXi Biologics Employees
WuXi Biologics had 13,252 employees as of December 31, 2025. The number of employees increased by 677 or 5.38% compared to the previous year.
Employees
13,252
Change (1Y)
677
Growth (1Y)
5.38%
Revenue / Employee
1.83M HKD
Profits / Employee
412.17K HKD
Market Cap
140.44B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Innovent Biologics | 7,502 |
| Akeso | 3,761 |
| Sichuan Kelun-Biotech Biopharmaceutical | 2,045 |
| Sino Biopharmaceutical | 21,435 |
| RemeGen | 3,048 |
| BeOne Medicines AG | 12,000 |
| 3SBio | 6,109 |
| Shanghai Junshi Biosciences | 2,903 |
WuXi Biologics News
- 9 hours ago - WuXi Biologics Releases 2025 Sustainability Report, Advancing Sustainable Growth and Improving Healthcare Access - PRNewsWire
- 5 days ago - WuXi Biologics Chengdu Microbial Commercial Manufacturing Site Achieves Structural Completion and Key Equipment Arrival - PRNewsWire
- 6 days ago - WuXi Biologics Receives South Korea MFDS GMP Certification to Enable Commercial Manufacturing of Bispecific Antibody Therapeutics - PRNewsWire
- 12 days ago - WuXi Biologics Recognized by Morningstar Sustainalytics as Industry and Regional ESG Leader for Sixth Year - PRNewsWire
- 14 days ago - WuXi Biologics Achieves ISO 13485 Certification, Signifying Strong Capabilities in Drug-Device Combination Product Development and Manufacturing - PRNewsWire
- 4 weeks ago - WuXi Biologics Honored with CDMO Leadership Awards for Ninth Consecutive Year - PRNewsWire
- 5 weeks ago - WuXi Biologics Earnings Call Transcript: H2 2025 - Transcripts
- 5 weeks ago - WuXi Biologics Reports Record 2025 Annual Results, Operational Excellence Driven by Digital-Native Architecture - PRNewsWire